Japan’s Doshisha University Develops Substance To Suppress Alzheimer’s Disease
This article was originally published in PharmAsia News
Executive Summary
Japan Doshisha University’s Professor Satoru Funamoto and his team have developed a new substance that suppresses the generation of the protein amyloid beta, thought to be the cause of Alzheimer’s disease.